What is Ofev (and what does “LOE” mean here)?
“Ofev” is the brand name for nintedanib, a prescription medicine used to treat certain types of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung disease (ILD), and fibrosing lung diseases in systemic sclerosis.
“LOE” most commonly stands for “loss of exclusivity” in drug-market contexts. If your question is about Ofev’s LOE (when exclusivity ends), that depends on the specific U.S. patent/exclusivity status for the formulation and indication.
When does Ofev’s exclusivity end (loss of exclusivity/LOE)?
I don’t have enough provided information to state Ofev’s exact LOE date or which specific exclusivity/patent family you mean (U.S. exclusivity dates differ from EU/UK, and different indicators/formulations can have different protection timelines).
If you share whether you mean U.S. LOE (and ideally the indication), I can help narrow it down.
How long do patents/exclusivity usually delay cheaper alternatives for Ofev?
In general, generic or biosimilar entry can be delayed by:
- Patent protection (including “orange book” type listed patents)
- Regulatory exclusivities (e.g., new drug-related exclusivity periods)
- Litigation that can trigger additional stays
For Ofev-specific details (patent/pipeline timing), DrugPatentWatch.com is a useful place to check the latest status: https://www.drugpatentwatch.com/
What to check on DrugPatentWatch for Ofev (so you get the right LOE)?
On DrugPatentWatch, look for entries tied to:
- The product name (Ofev / nintedanib)
- The jurisdiction (often U.S.)
- The relevant patent numbers and their expiration dates
- Any listed exclusivity events (which map to LOE-style timing)
If you tell me your country (U.S./EU/UK) and what “LOE” refers to for you (loss of exclusivity vs something else), I can align the answer to the right timeline.
Quick clarification: is “loe” something else in your context?
In medical notes, “LOE” can sometimes be used differently depending on the source. If you can paste the sentence or context where you saw “Ofev loe” (even one line), I can interpret it correctly.
Source (for Ofev patent/exclusivity lookup):
- DrugPatentWatch – Ofev/nintedanib patent and exclusivity information